TNSN91049A1 - Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique - Google Patents

Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique

Info

Publication number
TNSN91049A1
TNSN91049A1 TNTNSN91049A TNSN91049A TNSN91049A1 TN SN91049 A1 TNSN91049 A1 TN SN91049A1 TN TNSN91049 A TNTNSN91049 A TN TNSN91049A TN SN91049 A TNSN91049 A TN SN91049A TN SN91049 A1 TNSN91049 A1 TN SN91049A1
Authority
TN
Tunisia
Prior art keywords
carbon atoms
processes
preparation
pharmaceutical use
atoms
Prior art date
Application number
TNTNSN91049A
Other languages
English (en)
French (fr)
Inventor
Elof Brandstrom Arne
Lennart Lindberg Per
Elisabeth Sunden Gunnel
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of TNSN91049A1 publication Critical patent/TNSN91049A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
TNTNSN91049A 1990-06-20 1991-06-19 Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique TNSN91049A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (sv) 1990-06-20 1990-06-20 New compounds

Publications (1)

Publication Number Publication Date
TNSN91049A1 true TNSN91049A1 (fr) 1992-10-25

Family

ID=20379831

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN91049A TNSN91049A1 (fr) 1990-06-20 1991-06-19 Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique

Country Status (27)

Country Link
EP (1) EP0535081A1 (cs)
JP (1) JPH05507713A (cs)
CN (1) CN1058212A (cs)
AP (1) AP215A (cs)
AU (1) AU649453B2 (cs)
BG (1) BG97200A (cs)
CA (1) CA2083714A1 (cs)
CZ (1) CZ279772B6 (cs)
FI (1) FI925766A7 (cs)
HU (1) HUT62881A (cs)
IE (1) IE912025A1 (cs)
IL (1) IL98470A0 (cs)
IS (1) IS3721A7 (cs)
LT (2) LT3952B (cs)
LV (1) LV10953A (cs)
MA (1) MA22199A1 (cs)
NO (1) NO924775D0 (cs)
NZ (1) NZ238546A (cs)
OA (1) OA09682A (cs)
PT (1) PT98035A (cs)
RO (1) RO110493B1 (cs)
SE (1) SE9002206D0 (cs)
TN (1) TNSN91049A1 (cs)
TW (1) TW216418B (cs)
WO (1) WO1991019711A1 (cs)
YU (1) YU104191A (cs)
ZA (2) ZA914296B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
EP1257269B1 (en) 2000-02-24 2004-11-03 Kopran Research Laboratories Limited Orally administrable acid stable anti-ulcer benzimidazole derivatives
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
MXPA04009968A (es) 2002-04-09 2004-12-13 Flamel Tech Sa Formulacion farmaceutica oral bajo forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de principio (s) activo (s).
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
CA2540308C (en) 2003-09-26 2013-08-06 Alza Corporation Drug coating providing high drug loading and methods for providing the same
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) * 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
WO2007122686A1 (ja) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. ベンズイミダゾール化合物
ES2511792T3 (es) 2006-07-25 2014-10-23 Vecta Ltd. Composiciones y métodos para la inhibición de la secreción de ácido gástrico usando derivados de pequeños ácidos dicarboxílicos en combinación con IBP
WO2008047681A1 (fr) * 2006-10-13 2008-04-24 Eisai R & D Management Co., Ltd. Benzimidazole présentant une activité inhibitrice de la sécrétion d'acide gastrique
MX2011002515A (es) 2008-09-09 2011-04-07 Astrazeneca Ab Metodo de administracion de una composicion farmaceutica a un paciente que lo necesita.
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2519229A2 (en) 2009-12-29 2012-11-07 Novartis AG New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
NZ779170A (en) * 2016-09-14 2025-08-29 Univ Nat Taiwan Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (cs) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4738975A (en) 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
AU2621888A (en) * 1987-10-30 1989-05-23 Aktiebolaget Hassle Omeprazole for treatment of diseases related to bone loss
ZA889194B (en) * 1987-12-11 1989-08-30 Byk Gulden Lomberg Chemisch Fa Novel benzimidazole derivatives
AU3690289A (en) * 1988-05-25 1989-12-12 Byk Gulden Lomberg Chemische Fabrik Gmbh New fluoralkoxy compounds

Also Published As

Publication number Publication date
LTIP1713A (en) 1995-08-25
NO924775L (no) 1992-12-10
WO1991019711A1 (en) 1991-12-26
CA2083714A1 (en) 1991-12-21
AU649453B2 (en) 1994-05-26
IL98470A0 (en) 1992-07-15
IE912025A1 (en) 1992-01-01
NO924775D0 (no) 1992-12-10
EP0535081A1 (en) 1993-04-07
ZA914297B (en) 1992-03-25
LT3977B (en) 1996-06-25
LT3952B (en) 1996-05-27
IS3721A7 (is) 1991-12-21
AP9100285A0 (en) 1991-07-31
JPH05507713A (ja) 1993-11-04
CZ279772B6 (cs) 1995-06-14
HUT62881A (en) 1993-06-28
NZ238546A (en) 1994-03-25
OA09682A (en) 1993-05-15
MA22199A1 (fr) 1992-04-01
HU9204033D0 (en) 1993-03-29
ZA914296B (en) 1992-03-25
RO110493B1 (ro) 1996-01-30
LV10953A (lv) 1995-12-20
SE9002206D0 (sv) 1990-06-20
LTIP1712A (en) 1995-08-25
FI925766A0 (fi) 1992-12-18
TW216418B (cs) 1993-11-21
BG97200A (bg) 1993-12-24
YU104191A (sh) 1994-01-20
FI925766A7 (fi) 1992-12-18
CS189491A3 (en) 1992-04-15
AU8009791A (en) 1992-01-07
AP215A (en) 1992-09-02
CN1058212A (zh) 1992-01-29
PT98035A (pt) 1992-03-31

Similar Documents

Publication Publication Date Title
TNSN91049A1 (fr) Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique
TNSN91050A1 (fr) Derives dialkoxy-pyridinyl-benzimidazole, procedes en vue de leur preparation, et leur emploi pharmaceutique
FR2439187A1 (fr) Derives de 1-piperazine-carboxamides et -carbothioamides substitues, procede de preparation et compositions pharmaceutiques les contenant
TNSN97110A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN96161A1 (fr) Derives de la quinoleine et de quinazoline nouveaux procede pour leur preparation et formulations pharmaceutiques les contenant.
BE903183A (fr) Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant
BE905890A (fr) Anticorps monoclonaux a reaction croisee et protection croisee vis-a-vis des serotypes de p.aeruginosa.
BE1000201A4 (fr) Composes antibiotiques, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2438654A1 (fr) Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose
FR2424259A1 (fr) Esters de l'acide ((trifluoromethyl-5 pyridyloxy-2)-4 phenoxy)-4 pentene-2 oique utiles comme herbicides
KR870007118A (ko) 광학적으로 순수한 화합물 및 그의 제조 방법
FR2455587A1 (fr) Derives de benzimidazole, leur preparation et utilisation dans le traitement des affections cardiovasculaires et compositions les contenant
TNSN95062A1 (fr) Nouveaux derives dialkoxy-pyridinyle-benzimidazole
FR2443471A1 (fr) Derives du type thiazolidine de la progesterone utiles notamment comme precurseurs de medicaments antiacne et antiseborrhee
KR920703082A (ko) 어류 질병의 예방 및 치료제
Hessler et al. Lethal toxoplasmosis in a woolly monkey
FR2450817A1 (fr) Nouveaux oxime-ethers comportant un groupe pyridinyle, leur preparation et leur application therapeutique
FR2449401A1 (fr) Additifs pour insecticides par ingestion et/ou photodegradables, compositions insecticides contenant ces additifs et procede de lutte contre les insectes
FR2441617A1 (fr) Nouveaux derives de s-triazine, leur procede de preparation et compositions pharmaceutiques les contenant
BE1002181A3 (fr) 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines, de meme que le traitement de la leucemie et des tumeurs avec ces substances.
FR2603587A1 (fr) Derives de la 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonine (ou -1,4-benzoxazonine), procede pour leur preparation, medicaments les contenant et composes intermediaires
EP0378825A3 (fr) Esters alicycliques et leur utilisation à titre d'ingrédients parfumants
OA09665A (fr) Esters d'aminoacides de l'hydroquinone, leur procédé de préparation et compositions pharmaceutiques ou cosmétiques les contenant
PT84312B (fr) Procede de preparation de nouveaux derives du cyano-2 benzimidazole de compositions fungicides les contenant et de leurs associations avec d:autres fongicides
PT67623B (pt) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques